BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Monday, March 16, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 23, 2014
View Archived Issues
Phase I/II results for cell therapy-based replacement of retinal pigment epithelium
Read More
Oasmia's Paclical demonstrates positive risk/benefit profile in comparison with Taxol
Read More
Clinical response maintained with long-term brodalumab therapy in patients with psoriasis
Read More
PNPLA3 gene polymorphism associated with gallbladder cholesterol polyps
Read More
Critical Outcome Technologies and MD Anderson Cancer Center to evaluate COTI-2
Read More
SomaLogic and Novartis extend proteomics agreement
Read More
Addex and the Charcot-Marie-Tooth Association to advance ADX-71441
Read More
Asterias Biotherapeutics provides update on grant award from CIRM for AST-OPC1 trial
Read More
Phase II HIV treatment ibalizumab receives U.S. orphan drug designation
Read More
FDA grants tipelukast orphan drug status for IPF
Read More
Athera begins phase I trial of fully human antibody PC-mAb
Read More
Early clinical data for maternal immunization with the trivalent GBS vaccine
Read More
Aurigene Discovery Technologies discloses new TAK1 inhibitors
Read More
Novel anti-staphylococcal enterotoxin B MAbs divulged
Read More
In vivo testing of novel GPR-directed [99mTc]demobesin mimics
Read More
KU Leuven discloses new viral replication inhibitors for Flaviviridae infections
Read More
CHDI Foundation discloses novel HDAC4 inhibitors for Huntington's disease
Read More
Bristol-Myers Squibb reports new FFAR4 modulators
Read More
Omeros provides update on OMS-824 program
Read More
Repros Therapeutics reports results from long-term safety study of Androxal
Read More
Companies update development strategies in face of Ebola
Read More
GMI-1051 improves efficacy of antibiotic treatments in models of Pseudomonas infection
Read More
Relypsa submits NDA to FDA seeking approval of patiromer for hyperkalemia
Read More
EMA outlines recent efforts to expedite development of Ebola treatments
Read More
Phase III trials of secukinumab in ankylosing spondylitis meet primary endpoint
Read More
